R. Kanner

Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models

Stephen L. Hauser, Rob Knight, Sergio E. Baranzini, 2017, Proceedings of the National Academy of Sciences.

Long‐term evolution of multiple sclerosis disability in the treatment era

Alyssa H. Zhu, Nico Papinutto, Stephen L. Hauser, 2016, Annals of neurology.

The MS Microbiome Consortium (MSMC): an academic multi-disciplinary collaborative effort to elucidate the role of the gut microbiota in MS (P2.205)

R. Knight, S. Mazmanian, S. Baranzini, 2015 .

Gut dysbiosis is a feature of MS and it is characterized by bacteria able to regulate lymphocyte differentiation in vitro

Justine W. Debelius, Charlotte A. Nelson, R. Knight, 2016 .

Effect of oral versus injectable disease-modifying therapies on the epigenome-wide DNA methylation and gut microbiota in multiple sclerosis patients

Justine W. Debelius, R. Knight, S. Mazmanian, 2016 .